FBRX

Forte Biosciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD17.01

+0.01 (+0.08%)

Rating:C-

Company Profile

CEO

Paul A. Wagner

IPO Date

2017-04-13

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$17.05

Prev. Close

$17.00

Day Low

$16.80

Day High

$17.40

52W Low

$9.10

52W High

$35.80

Market Cap

$0.24B

Volume

0.05M

News SentimentBullish

Articles

Avg Positive

30.2%

Avg Negative

17.4%

Avg Neutral

52.4%

News Feed

Implied Volatility Surging for Forte Biosciences (FBRX) Stock Options

Zacks Investment Research·7/7/2021·↑ positive

Forte Biosciences, Inc. (FBRX) CEO Paul Wagner on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/11/2021·↓ negative

Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update

Business Wire·5/3/2021·↓ negative